HLS Therapeutics Inc. listed publicly on the TSXV in March 2018 by way of a Reverse Take-Over of Automodular Corporation. HLS is pleased to announce that Mr. Christopher Nutt, former President, Chief Executive Officer and Chief Financial Officer of Automodular Corporation has been appointed Automodular Claims Administrator and will continue to support HLS in this capacity.